§2080.230. Designated Controlled Substances and Other Selected Drugs

For tracking purposes, the Department, upon recommendation of the PMPAC, may designate and list drugs, other substances, and immediate precursors as:

 

a)         A Schedule I if the Department finds that:

 

1)         the substance has high potential for abuse; and

 

2)         the substance has no currently accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision [720 ILCS 570/203]. 

 

b)         A Schedule II if the Department finds that:

 

1)         the substance has high potential for abuse;

 

2)         the substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and

 

3)         the abuse of the substance may lead to severe psychological or physiological dependence [720 ILCS 570/205].

 

c)         A Schedule III if the Department finds that:

 

1)         the substance has a potential for abuse less than the substances listed in Schedules I and II;

 

2)         the substance has currently accepted medical use in treatment in the United States; and

 

3)         abuse of the substance may lead to moderate or low physiological dependence or high psychological dependence [720 ILCS 570/207].

 

d)         A Schedule IV if the Department finds that:

 

1)         the substance has a low potential for abuse relative to substances in Schedule III;

 

2)         the substance has currently accepted medical use in treatment in the United States; and

 

3)         abuse of the substance may lead to limited physiological dependence or psychological dependence relative to the substances in Schedule III [720 ILCS 570/209].

 

e)         A Schedule V if the Department finds that:

 

1)         the substance has low potential for abuse relative to the controlled substances listed in Schedule IV;

 

2)         the substance has currently accepted medical use in treatment in the United States; and

 

3)         abuse of the substance may lead to limited physiological dependence or psychological dependence relative to the substances in Schedule IV, or the substance is a targeted methamphetamine precursor as defined in the Methamphetamine Precursor Control Act [720 ILCS 648]. [720 ILCS 570/211]

 

f)         Other Selected Drugs, including:

 

1)         those medications that may contribute to clinical reviews of scheduled medications;

 

2)         those medications determined to need additional monitoring or to assist in facilitating medication optimization and utilization; and

 

3)         the dispensing of Naloxone for opioid overdose prevention.

 

(Source:  Amended at 47 Ill. Reg. 13500, effective September 8, 2023)